AGN 225660
AGN 225660 is a multi-prostanoid receptor antagonist with human IC50 values of 70, 70, 5, 220 and 180 nM for EP1, EP4, TP, DP1, FP. AGN 225660 inhibits secretion of RANTES, IL-8, MCP-1, IL-12p70, and IL-23. AGN 225660 exhibits good ocular bioavailability and reduces ocular inflammation linked to phacoemulsification surgery and uveitis.
For research use only. We do not sell to patients.
- CAS No.: 1354060-46-0
- Formula: C20H27ClN2O3
- Molecular Weight:378.89
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
TP 5 nM (IC50) |
EP1 70 nM (IC50) |
EP4 70 nM (IC50) |
FP 180 nM (IC50) |
DP1 220 nM (IC50) |
IL-8 |
IL-12 |
IL-23 |
AGN 225660 potently antagonizes pro-inflammatory human recombinant prostanoid receptors (EP1, EP4, TP, DP1, FP) with IC50 values ranging from 5 to 220 nM, and has weak activity at anti-inflammatory receptors (EP2, EP3, IP) with IC50 values ≥1100 nM in HEK-293 transfectants[1].
AGN 225660 (1-10 μM; 24 h) dose-dependently and significantly inhibits TNFα-induced IL-8, MCP-1, and RANTES secretion in human monocyte-derived
dendritic cells[1].
AGN 225660 (1-10 μM; 18-20 h) significantly inhibits LPS (HY-D1056)-induced IL-12p70 and IL-23 secretion by 65-75% in human monocyte-derived
dendritic cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
AGN 225660 (0.1-0.3%; topical) completely inhibits leukocyte infiltration in Arachidonic acid (HY-109590)-induced uveitis in Dutch Belted rabbits at the 0.3% dose[1].
AGN 225660 (0.3%; topical; twice daily) reduces phacoemulsification surgery-induced anterior chamber flare by ~50% in African green monkeys[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:LEW/SsNHsd (male, 180-200 g, LPS-induced)[1]
-
Dosage:1%
-
Administration:topical
-
Result:Reduced aqueous humor protein concentration to <20 mg/mL vs vehicle control.
Significantly reduced leukocyte infiltration into the anterior chamber.
-
Animal Model:Dutch Belted pigmented (male/female, 2.5-3 kg, Arachidonic acid-induced)[1]
-
Dosage:0.1%; 0.3%
-
Administration:topical
-
Result:Produced marginal inhibition of leukocyte infiltration at 0.1% dose.
Totally inhibited arachidonic acid-induced leukocyte infiltration into the anterior chamber at 0.3% dose.
-
Animal Model:Chlorocebus sabaeus (8 males, 7 females, 3.2-6.7 kg, phacoemulsification surgery-induced)[1]
-
Dosage:0.3%
-
Administration:topical; twice daily
-
Result:Reduced laser flare responses by ~50% relative to PBS-treated controls on day 1 post-surgery.
Chemical Information
-
CAS No. 1354060-46-0
-
Molecular Weight 378.89
-
Formula C20H27ClN2O3
-
SMILES
O=C(CCC1=NN(CC2=CC(Cl)=CC=C2OCC(CC)CC)C(C)=C1)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz